Targeting of p38 mitogen-activated protein kinases to early growth response gene 1 (EGR-1) in the human paclitaxel-resistance ovarian carcinoma cells.
about
Nilotinib counteracts P-glycoprotein-mediated multidrug resistance and synergizes the antitumoral effect of doxorubicin in soft tissue sarcomasAnalysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancerp38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell line.EGR1 interacts with TBX2 and functions as a tumor suppressor in rhabdomyosarcoma.Dioscin suppresses the viability of ovarian cancer cells by regulating the VEGFR2 and PI3K/AKT/MAPK signaling pathways.
P2860
Targeting of p38 mitogen-activated protein kinases to early growth response gene 1 (EGR-1) in the human paclitaxel-resistance ovarian carcinoma cells.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Targeting of p38 mitogen-activ ...... tance ovarian carcinoma cells.
@ast
Targeting of p38 mitogen-activ ...... tance ovarian carcinoma cells.
@en
type
label
Targeting of p38 mitogen-activ ...... tance ovarian carcinoma cells.
@ast
Targeting of p38 mitogen-activ ...... tance ovarian carcinoma cells.
@en
prefLabel
Targeting of p38 mitogen-activ ...... tance ovarian carcinoma cells.
@ast
Targeting of p38 mitogen-activ ...... tance ovarian carcinoma cells.
@en
P2093
P1476
Targeting of p38 mitogen-activ ...... tance ovarian carcinoma cells.
@en
P2093
P2888
P304
P356
10.1007/S11596-008-0417-X
P577
2008-08-15T00:00:00Z
P6179
1034625948